Skip to content

Liquichek 171Recalls & reported problems

Bio-Rad Laboratories, Inc. · Liquichek Diabetes Control Level 1 (A human whole blood assayed diabetes control.) · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00847661000839), received between Sep 25, 2018 and Sep 25, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Human-Device Interface Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Human-Device Interface Problem1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 25, 2018Human-Device Interface Problem; Human-Device Interface Problem

    ON SEPTEMBER 06, 2018, BIO-RAD QSD, (B)(4) RECEIVED A REPORT FOR A POTENTIAL ADVERSE EVENT WHERE A LABORATORY TECHNICIAN SPLASHED LIQUICHEK DIABETES CONTROL LOT # 38560 INTO HER EYE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7906291 ↗

Other CONTROL, HEMOGLOBIN devices

All CONTROL, HEMOGLOBIN devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page